journal article·2014-06

Small peptide-modified nanostructured lipid carriers distribution and targeting to EGFR-overexpressing tumorin vivo

Cuiyan Han, Yao Li, Mingshuang Sun, Chang Liu, Xiaoxing Ma, Xinggang Yang, Yue Yuan, Weisan Pan

Publisher page

Abstract

Ala-Glu-Tyr-Leu-Arg (AEYLR) was identified as a small peptide ligand targeting epidermal growth factor receptors (EGFR) in vitro in our previous study. The in vivo targeting ability of AEYLR and AEYLR-conjugated nanostructured lipid carriers (NLC) was studied in this paper. Near-infrared fluorescent (NIFR) dye 1,1'-dioctadecyltetramethyl indotricarbocyanine iodide (DiR)-loaded and AEYLR-modified NLC (A-D-NLC) were prepared. The average diameter, zeta potential, coupling efficiency between AEYLR and NLC and the amount of DiR released from A-D-NLC were used to evaluate their in vivo characteristics. AEYLR was labeled by Cy7 and A549 xenograft tumor-bearing mice model were establish. The in vivo distribution in tumor-bearing mice of A-D-NLC and Cy7-AEYLR was examined using NIRF imaging experiments at different times post-injection. AEYLR and AEYLR-conjugated NLC showed obvious targeting to A549 xenograft tumor compared with the control group. These results suggested that AEYLR-modified NLC could be considered as a promising targeted delivery system for combination cancer chemotherapy to improve therapeutic efficacy and to minimize adverse effects.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (36)

Show source-provided references
1. Ahles TA · Nat Rev Cancer · 2007 · 7 · 19210.1038/nrc2073 ↗
2. 10.1081/PB-12002711610.1081/PB-120027116 ↗
3. 10.2174/15672011280038908910.2174/156720112800389089 ↗
4. Bondì ML · Drug Deliv · 2007 · 14 · 6110.1080/10717540600739914 ↗
5. Cho H · Nanomedicine · 2012 · 8 · 22810.1016/j.nano.2011.06.009 ↗
6. Ekstrand AJ · Cancer Res · 1991 · 51 · 2164
7. 10.1016/j.biomaterials.2011.09.03510.1016/j.biomaterials.2011.09.035 ↗
8. Gru¨nwald V · J Nati Cancer Inst · 2003 · 95 · 85110.1093/jnci/95.12.851 ↗
9. Han CY · Int J Nanomedicine · 2013 · 8 · 1541
10. Han RL · J Boil · 2008 · 7 · 1210.1186/jbiol69 ↗
11. Hara T · JACC Cardivvasc Imaging · 2012 · 5 · 60710.1016/j.jcmg.2012.01.017 ↗
12. Hwang SY · Bioconjug Chem · 2010 · 21 · 34510.1021/bc9004409 ↗
13. 10.1016/j.ijbiomac.2012.01.02410.1016/j.ijbiomac.2012.01.024 ↗
14. Jie LY · Int J Nanomedicine · 2012 · 7 · 3981
15. Johnstone RW · Cell · 2002 · 108 · 15310.1016/S0092-8674(02)00625-6 ↗
16. Kircher MF · Bioconjugate Chem · 2004 · 15 · 24210.1021/bc034151d ↗
17. Li F · Int J Pharm · 2010 · 393 · 20410.1016/j.ijpharm.2010.04.005 ↗
18. 10.1016/j.colsurfb.2011.02.03810.1016/j.colsurfb.2011.02.038 ↗
19. 10.1021/mp200402e10.1021/mp200402e ↗
20. Liu FS · Taiwan J Obstet Gynecol · 2009 · 48 · 23910.1016/S1028-4559(09)60296-5 ↗
21. 10.1096/fj.05-4058com10.1096/fj.05-4058com ↗
22. Li Z · Nanoscale · 2012 · 4 · 709710.1039/c2nr32047a ↗
23. Malam Y · Trends Pharmacol Sci · 2009 · 30 · 59210.1016/j.tips.2009.08.004 ↗
24. Marcucci F · Drug Discov Today · 2004 · 9 · 21910.1016/S1359-6446(03)02988-X ↗
25. Meghna T · Anticancer Drugs · 2011 · 22 · 94910.1097/CAD.0b013e32834a4554 ↗
26. Pan XG · Bioconjug Chem · 2007 · 18 · 10110.1021/bc060174r ↗
27. Saha RN · Mol Membr Biol · 2010 · 27 · 21510.3109/09687688.2010.510804 ↗
28. Su Z · Mol Pharm · 2011 · 8 · 164110.1021/mp100463n ↗
29. Torchilin VP · AAPS J · 2007 · 9 · 12810.1208/aapsj0902015 ↗
30. Tseng CL · Biomaterials · 2009 · 30 · 347610.1016/j.biomaterials.2009.03.010 ↗
31. Wu Y · Mol Imaging Biol · 2006 · 8 · 22610.1007/s11307-006-0041-8 ↗
32. 10.1248/cpb.58.65610.1248/cpb.58.656 ↗
33. Zhang XX · J Pharm Pharmacol · 2008 · 60 · 107710.1211/jpp.60.8.0014 ↗
34. 10.1158/1078-0432.CCR-03-074010.1158/1078-0432.CCR-03-0740 ↗
35. Zhao X · J Chromatogr B · 2011 · 879 · 372110.1016/j.jchromb.2011.10.015 ↗
36. Zhou H · Med Hypotheses · 2007 · 69 · 123010.1016/j.mehy.2007.03.038 ↗